Turns out, the drugs millions are taking for weight loss and diabetes might be moonlighting as cancer fighters. That's the takeaway from a new study that found women on medications like Ozempic and Wegovy were significantly less likely to develop breast cancer.
We’re talking about a 30% lower risk. Let that satisfying number sink in. Researchers sifted through the health records of over 110,000 women, and the results are making a lot of heads turn. These GLP-1 drugs, as they’re called, mimic a natural hormone that helps manage blood sugar and appetite. They've been a hit for weight loss, and now, it seems they might be doing much more.
The Unexpected Cancer Connection
It’s not just breast cancer. Other studies have hinted at lower cancer rates across the board for GLP-1 users. Dr. Elizabeth McDonald, a professor at the University of Pennsylvania, put it dryly: this observational study, while not a clinical trial, adds to the evidence that these drugs could be cancer prevention tools. Her team is already planning a full-blown clinical trial to see if these meds can prevent breast cancer in high-risk women. Because apparently, that’s where we are now: your weight-loss shot might also be your cancer shield.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxMcDonald finds these drugs fascinating precisely because they weren't designed for cancer. Yet, they seem to be affecting multiple biological pathways linked to tumor development. It’s like finding out your new smart fridge can also do your taxes.
The study zeroed in on 111,646 women between 45 and 80 with a BMI of 25 or higher, all of whom had breast imaging through Penn Medicine. About 13.7% of them were on GLP-1s. The punchline? Those GLP-1 users had a 35.1% lower chance of developing breast cancer in the full group, and a still impressive 30.5% reduction in a matched group with similar characteristics. Which, if you think about it, is both impressive and slightly terrifying for anyone not on them.
More Than Just Weight Loss
Part of the benefit likely comes from the weight loss itself. Carrying extra weight, especially post-menopause, is a known risk factor for breast cancer. But scientists suspect there’s more going on. GLP-1 drugs are known to reduce inflammation and affect metabolism and gene activity. This combination of effects could be slowing or even preventing tumor growth. It's like they're not just helping you fit into your old jeans, but also tidying up your cellular house to keep the bad stuff out.
Currently, options for preventing breast cancer are pretty limited – regular screenings, some risky surgeries, and a drug called Tamoxifen with its own set of side effects. Given that millions are already using GLP-1s, researchers see them as a promising avenue for prevention. As McDonald notes, the goal is simple: find better ways to prevent breast cancer. And if that better way comes with the added bonus of fitting into your old jeans, well, that’s just good marketing.
